Showing 5561-5580 of 8668 for: Cochrane Systematic Reviews Back
- Oral methylxanthines for bronchiectasis
Cochrane Systematic Reviews, 24-Apr-2000
Bronchiectasis is characterised by chronic sputum production, bronchial wall dilation, recurrent infection and airflow limitation. Methylxanthines are used in the management of airflow limitation associated with asthma and COPD, where they are also purpor
- Oral misoprostol for induction of labour
Cochrane Systematic Reviews, 13-Jun-2014
Misoprostol is an orally active prostaglandin. In most countries misoprostol is not licensed for labour induction, but its use is common because it is cheap and heat stable.
- Oral morphine for cancer pain
Cochrane Systematic Reviews, 22-Apr-2016
This is the third updated version of a Cochrane review first published in Issue 4, 2003 of The Cochrane Library and first updated in 2007. Morphine has been used for many years to relieve pain. Oral morphine in either immediate release or modified release
- Oral naltrexone maintenance treatment for opioid dependence
Cochrane Systematic Reviews, 13-Apr-2011
Research on clinical application of oral naltrexone agrees on several things. From a pharmacological perspective, naltrexone works. From an applied perspective, the medication compliance and the retention rates are poor.
- Oral non steroid anti-inflammatories for children and adults with bronchiectasis
Cochrane Systematic Reviews, 23-Mar-2009
Bronchiectasis is increasing recognised as a co-morbidity in many respiratory illness. Anti inflammatory drugs may reduce the inflammatory cascade and thus reduce symptoms and slow long term pulmonary decline.
- Oral non‐steroidal anti‐inflammatory drug therapy for lung disease in cystic fibrosis
Cochrane Systematic Reviews, 9-Sep-2019
Progressive lung damage causes most deaths in cystic fibrosis. Non-steroidal anti-inflammatory drugs (such as ibuprofen) may prevent progressive pulmonary deterioration and morbidity in cystic fibrosis. This is an update of a previously published review.
- Oral nonsteroidal anti‐inflammatory drugs (NSAIDs) for cancer pain in adults
Cochrane Systematic Reviews, 12-Jul-2017
Pain is a common symptom with cancer, and 30% to 50% of all people with cancer will experience moderate to severe pain that can have a major negative impact on their quality of life. Non-opioid drugs are commonly used to treat cancer pain, and are recomme
- Oral non‐steroidal anti‐inflammatory drugs (single dose) for perineal pain in the early postpartum period
Cochrane Systematic Reviews, 11-Jan-2021
Many women experience perineal pain after childbirth, especially after having sustained perineal trauma. Perineal pain-management strategies are an important part of postnatal care. Non-steroidal anti-inflammatory drugs (NSAIDs) are a commonly-used type o
- Oral nonsteroidal anti‐inflammatory drugs for fibromyalgia in adults
Cochrane Systematic Reviews, 27-Mar-2017
Oral nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used in the treatment of pain in fibromyalgia, despite being considered not to be effective.
- Oral nonsteroidal anti‐inflammatory drugs for neuropathic pain
Cochrane Systematic Reviews, 5-Oct-2015
Although often considered to be lacking adequate evidence, nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used in the management of neuropathic pain. Previous surveys found 18% to 47% of affected people reported using NSAIDs specifically for the
- Oral non‐steroidal anti‐inflammatory drugs versus other oral analgesic agents for acute soft tissue injury
Cochrane Systematic Reviews, 12-Aug-2020
Acute soft tissue injuries are common and costly. The best drug treatment for such injuries is not certain, although non-steroidal anti-inflammatory drugs (NSAIDs) are often recommended. There is concern about the use of oral opioids for acute pain leadin
- Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
Cochrane Systematic Reviews, 18-Oct-2004
Hot flushes and night sweats are common symptoms experienced by menopausal women. Hormone therapy (HT), containing oestrogens alone or oestrogens together with progestogens in a cyclic or continuous regimen, is often recommended for their alleviation.
- Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors
Cochrane Systematic Reviews, 2-Jul-2014
Iron deficiency is a significant cause of deferral in people wishing to donate blood. If iron removed from the body through blood donation is not replaced, then donors may become iron deficient. All donors are screened at each visit for low haemoglobin (H
- Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children
Cochrane Systematic Reviews, 3-Apr-2011
Otitis media with effusion (OME) is common and may cause hearing loss with associated developmental delay. Treatment remains controversial.
- Oral or transdermal opioids for osteoarthritis of the knee or hip
Cochrane Systematic Reviews, 17-Sep-2014
Osteoarthritis is the most common form of joint disease and the leading cause of pain and physical disability in older people. Opioids may be a viable treatment option if people have severe pain or if other analgesics are contraindicated. However, the evi
- Oral paliperidone for schizophrenia
Cochrane Systematic Reviews, 18-Apr-2012
Paliperidone, an active metabolite of risperidone, is now available in an oral formulation for daily use; an intramuscular formulation for monthly administration is expected to follow shortly. Oral paliperidone is available commercially only in an extende
- Oral paracetamol (acetaminophen) for cancer pain
Cochrane Systematic Reviews, 12-Jul-2017
Pain is a common symptom with cancer, and 30% to 50% of all people with cancer will experience moderate to severe pain that can have a major negative impact on their quality of life. Non-opioid drugs are commonly used to treat mild to moderate cancer pain
- Oral potassium iodide for the treatment of sporotrichosis
Cochrane Systematic Reviews, 7-Oct-2009
Sporotrichosis is a subacute or chronic disease, usually affecting the skin caused by a dimorphic (existing in two forms), aerobic (oxygen requiring) fungus called Sporothrix schenckii. Oral potassium iodide is widely used for cutaneous sporotrichosis in
- Oral prostaglandin E2 for induction of labour
Cochrane Systematic Reviews, 23-Apr-2001
This is one of a series of reviews of methods of cervical ripening and labour induction using standardized methodology.
- Oral protein calorie supplementation for children with chronic disease
Cochrane Systematic Reviews, 27-May-2015
Poor growth and nutritional status are common in children with chronic diseases. Oral protein calorie supplements are used to improve nutritional status in these children. These expensive products may be associated with some adverse effects, e.g. the deve
